These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22546752)

  • 21. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
    Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA
    Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of clinical and inflammatory markers of nonalcoholic fatty liver disease in postmenopausal women with metabolic syndrome.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Sandrim VC; Muniz LG; Nahas EA
    Metab Syndr Relat Disord; 2014 Aug; 12(6):330-8. PubMed ID: 25051240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI in identifying hepatic steatosis in obese children and relation to ultrasonography and metabolic findings.
    Pozzato C; Radaelli G; Dall'Asta C; Verduci E; Villa A; Villa C; Scaglioni S; Riva E; Pontiroli AE; Cornalba G; Giovannini M
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):493-9. PubMed ID: 18852643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease.
    Tsai CH; Li TC; Lin CC
    South Med J; 2008 Sep; 101(9):900-5. PubMed ID: 18708987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment.
    Goland S; Shimoni S; Zornitzki T; Knobler H; Azoulai O; Lutaty G; Melzer E; Orr A; Caspi A; Malnick S
    J Clin Gastroenterol; 2006; 40(10):949-55. PubMed ID: 17063117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
    Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
    Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case-control study on nutritional risk factors in non-alcoholic fatty liver disease in Indian population.
    Sathiaraj E; Chutke M; Reddy MY; Pratap N; Rao PN; Reddy DN; Raghunath M
    Eur J Clin Nutr; 2011 Apr; 65(4):533-7. PubMed ID: 21346716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease.
    Chen LW; Huang PR; Chien CH; Lin CL; Chien RN
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):173-181. PubMed ID: 30981560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study.
    Jarcuska P; Janicko M; Drazilová S; Senajová G; Veselíny E; Fedacko J; Siegfried L; Kristian P; Tkác M; Pella D; Mareková M; Gecková AM; Jarcuska P;
    Cent Eur J Public Health; 2014 Mar; 22 Suppl():S43-50. PubMed ID: 24847614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.
    Açikel M; Sunay S; Koplay M; Gündoğdu F; Karakelleoğlu S
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):273-9. PubMed ID: 19666428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
    Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
    Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese.
    Huang X; Xu M; Chen Y; Peng K; Huang Y; Wang P; Ding L; Lin L; Xu Y; Chen Y; Lu J; Wang W; Bi Y; Ning G
    Medicine (Baltimore); 2015 Oct; 94(40):e1682. PubMed ID: 26448014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females.
    Ishibashi E; Eguchi Y; Eguchi T; Matsunobu A; Oza N; Nakashita S; Kitajima Y; Kuroki S; Ozaki I; Kawaguchi Y; Ide Y; Yasutake T; Iwakiri R; Mizuta T; Ono N; Fujimoto K
    J Gastroenterol Hepatol; 2008 Jun; 23(6):908-13. PubMed ID: 18373563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy.
    Caserta CA; Pendino GM; Amante A; Vacalebre C; Fiorillo MT; Surace P; Messineo A; Surace M; Alicante S; Cotichini R; Zuin M; Rosmini F; Mele A; Marcucci F
    Am J Epidemiol; 2010 Jun; 171(11):1195-202. PubMed ID: 20457571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I.
    Arturi F; Succurro E; Procopio C; Pedace E; Mannino GC; Lugarà M; Procopio T; Andreozzi F; Sciacqua A; Hribal ML; Perticone F; Sesti G
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1640-4. PubMed ID: 21816784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.
    Younossi ZM; Otgonsuren M; Venkatesan C; Mishra A
    Metabolism; 2013 Mar; 62(3):352-60. PubMed ID: 22999011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
    Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
    Hsiao PJ; Kuo KK; Shin SJ; Yang YH; Lin WY; Yang JF; Chiu CC; Chuang WL; Tsai TR; Yu ML
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2118-23. PubMed ID: 18031368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
    Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.